News

Emdeon has acquired eRx Network (eRx). The transaction combines Emdeon’s existing pharmacy operations with eRx’s customer base, product innovation, customer support and pharmacy switching technology. In connection with

Omega Medical has selected Allscripts’ Practice Management and Payerpath claims management solution, for its physician practice clients across South Carolina and the surrounding states. Omega would deliver both

MDS has completed the divestiture of its phase II-IV operations to INC Research. Under the terms of the agreement, INC Research has acquired MDS Pharma Services’ phase II-IV

Roche has launched a new program to ease Tamiflu access to developing economies. The Tamiflu Reserves Program is designed as a pandemic insurance policy for the world’s developing

Graceway and Pfizer have entered into an acquisition and license agreement. Under the deal, Graceway will acquire the worldwide commercial rights for three investigational dermatological molecules from Pfizer,

Schering-Plough has announced the results from the Phase III Engage clinical trial demonstrating that a single injection of corifollitropin alfa, achieved similar efficacy to recombinant follicle stimulating hormone

FDA has granted marketing approval for AMAG’s Feraheme (ferumoxytol) Injection. It is for intravenous (IV) use as an iron replacement therapy, for the treatment of iron deficiency anemia

Sepracor has completed the analysis and validation of the preliminary results of a phase II, 514-patient study. It evaluated the efficacy and safety of SEP-225289 for the treatment

Morphotek has signed a research collaboration agreement with Synageva to express and develop therapeutic monoclonal antibodies for the potential treatment of various forms of cancer and infectious disease.